User: Guest

MOLECULAR DIAGNOSTICS

Global Market Trajectory & Analytics

MCP-1226

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

12781
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1534
Interactions with Platform & by Email

PARTICIPANTS

383
Unique # Participated

VALIDATIONS

172
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

AUG 2020

TABLES

315

PAGES

880

EDITION

16

PRICE

USD $5600


The global market for Molecular Diagnostics is expected witness revenues spike by 20.7% in the year 2020 and thereafter continue to grow and reach US$19.9 billion by the year 2027, trailing a post COVID-19 CAGR of 9.8% over the analysisperiod2020 through 2027. Molecular diagnostic testing for COVID-19 is rapidly evolving each week as global infections continue to surge. Countries worldwide are stepping up testing rates significantly in a bid to control the spread of infections & mortality rates. India which is now in the eye of the pandemic storm is currently carrying out 1 million COVID-19 tests daily. The pressing requirement for massive and universal testing is leading to introduction of various technologies for COVID-19 diagnostics, providing access to new tests in response to the pandemic. These diagnostic techniques, along with approaches to develop new vaccines or therapies, rely heavily on molecules from the coronavirus, including nucleic acids such as DNA or RNA and proteins. COVID-19 diagnostics essentially screen samples for the viral RNA or the presence of antibodies for viral RNA. While viral RNA tests identify presence of SARS-CoV-2 infection from swab samples by reverse transcription of polymerase chain reaction (RT-PCR), immunoassay-based antibody tests delve deeper into the serum and diagnose presence of antibodies produced in the body and quantify the impact and resultant immunity attained. While RT-PCR tests are direct tests, antibody tests are to be paired with viral RNA tests and are not conclusive on their own and sometimes yield inconsistent results if the individual's immune system produces antibodies later than the time of the test.


As the gold standard in molecular diagnostics, PCR isa dominant way through which global healthcare systems are testing for Covid-19. These tests work by detecting the viral genomic material of the virus namely ribonucleic acid (RNA) which remains in the body while the virus replicates. Testing for COVID-19 detects genetic material of the virus from the lower and upper respiratory tract. Molecular tests use swab collection of the specimen from the mouth or nose of a person. The specimen is processed for the specific ribonucleic acid (RNA) or genetic signature of the SARS-CoV-2. Molecular tests are commonly used in acute respiratory infections for detecting the viral genetic material in specimens. The approach relies on reverse transcription polymerase chain reaction (RT-PCR) that involves copying and comparison of the genetic material from a specimen to the virus' genetic sequence. Molecular testing uses swab or saliva samples to detect the virus. The swab test involves insertion of a six inch swab into the back side of the nasal passage. The swab is rotated several times for collecting the sample from both nostrils, which is sent to a laboratory for testing. Abbott Laboratories has launched a point-of-care swab test intended to deliver test results in around five minutes. The availability of point-of-care or portable test kits allows sample collection in provider offices and even at a drive-thru site.


The FDA has recently authorized the foremost molecular test that considers saliva specimen. Offered by Rutgers' RUCDR Infinite Biologics, the test is accurate and addresses shortage of swabs. The FDA has allowed several companies to distribute molecular tests and notified various players to start testing people using internally-validated tests. Molecular diagnostics are gaining growing confidence in COVID 19 testing by virtue of their high specificity and accuracy RT-PCR tests in comparison with the cost efficient alternative - antibody tests that falter at authenticity of findings due to inconclusive early stage viral presence. The phenomenal rise in the COVID cases worldwide is poised to grow the market for molecular diagnostics multi-fold. With the recovery across the Asian, European and American markets falling into different stages, it is vital for the molecular diagnostics companies to be present in the right markets at the right time, vet their resources, scale up production, and optimize supply chains to overcome market specific hurdles, shortages, supply disruptions to pocket healthy volumes as long as the demand exists. Volumes may recede as the global infections go down gradually, or are contingent upon the development of the vaccine by 2021. In the post COVID-19 period, demand for molecular diagnostics will grow stronger with pent-up demand for infectious disease testing such as tuberculosis, hepatitis C, hepatitis B, HPV, and also STDs.

Abbott Laboratories; Abbott Molecular; Becton, Dickinson and Company; bioMérieux SA; Cepheid; F. Hoffmann-La Roche Ltd.; Grifols International, S.A.; Hologic, Inc.; QIAGEN N.V.; QuestDiagnostics, Inc.; Siemens Healthcare GmbH; Tecan Group Ltd.; The ELITechGroup; Thermo Fisher Scientific
» Component (Reagents & Kits, Instruments, Software & Service) » Technology (PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays, Other Technologies) » Application (Infectious Disease, Oncology Testing, Genetic Testing, Other Applications)
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
EXHIBIT: Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As on August 27, 2020
Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
RT-PCR Emerges as the Frontline Technology for Testing COVID-19
Molecular Diagnostic Companies Re-strategize Logistics to Stay at the Top End of the Game
Select Tests Introduced for COVID-19
COVID-19 Plunges Fortunes of Non- COVID Diagnostics
Cancer Testing Dives During First Half of 2020
Myeloproliferative Neoplasm Tests Suffer the Brunt of CoVID-19 Curbs
Labs Embark New Journeys to Retain Overall Volumes
Molecular Diagnostics: An Introduction
Types of Molecular Diagnostics Tests
Market Outlook
Major Growth Drivers
Developing Countries Offer Strong Growth Prospects
PCR Technology Leads the MDx Market
Infectious Diseases: The Largest Application Market
Reagents and Kits Dominate the Molecular Diagnostics Market
Competition
EXHIBIT: Global Molecular Diagnostics Market by Leading Player (2019)
EXHIBIT: Global Molecular Diagnostics Market for Clostridium difficile by Leading Player: 2019
Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Faster Screening Necessitates Point-of-Care Diagnostics for COVID-19
Molecular Diagnostics Market Eyes Transformational Impact of Proactive Diagnostics
Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
Isothermal Amplification: An Alternative to RT-PCR for COVID-19 Testing
Technological Innovations Set to Drive Market Growth
New Product Developments
Digitalization Trends Benefit Growth
Growing Role of Molecular Diagnostics in Personalized Medicine
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Companion Diagnostics Drive Personalized Medicine
Biomarkers as Companion Diagnostics
Oncology-Based Molecular Diagnostics Lead Growth
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
New Applications Hold Promising Potential
Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
Rising Emphasis on Lab Automation to Augur Well for Market Growth
EXHIBIT: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
Nanotechnology for Molecular Diagnostics
Growing Popularity of Chemo-Sensitivity Testing of CTCs
Genetic Disease Testing Offers Bright Prospects
Genetic Testing to Aid in Personalized Medicine
Pharmacogenomics Development Augurs Growth of Genetic Testing Market
Non-Invasive Prenatal Diagnostics – The Way Ahead
Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
Growing Incidence of Infectious Diseases Spurs Opportunities
EXHIBIT: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Rising Incidence of Hospital Acquired Infections Propels Market Growth
Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
EXHIBIT: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
EXHIBIT: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
Home HIV Testing Emerges as a Lucrative Option
Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
EXHIBIT: Hepatitis B prevalence Worldwide by Region
HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
EXHIBIT: HPV Associated Disorders Market by Indication: 2019
Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
EXHIBIT: Number of New Cervix Uteri Cases in the World by Region (2018)
Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
Rise in Healthcare Expenditure to Drive Growth
EXHIBIT 15: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population Drives Molecular Diagnostics Market
EXHIBIT: Elderly Healthcare Expenditure as a % of GDP
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
GEOGRAPHIC MARKET ANALYSIS
United States
Market Analytics
Market Overview
EXHIBIT: Healthcare Spending as a % of GDP in the US: 2010-2020
US Emerges as a Major Market for COVID-19 Tests
Infectious Disease Testing Contributes to High Growth
Ageing Demographics: Major Driving Factor
Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
Molecular Diagnostics Tests Gain Share in STD Testing Domain
HPV Testing Market: A Review
US Personalized Medicine Market to Offer Significant Opportunities
Companion Diagnostics Market in the US
Burgeoning Potential for Genetic Testing
USA Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
USA Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
USA 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
USA Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
USA 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
USA Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
USA 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Canada
Canada Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Canada Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Canada 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Canada Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Canada 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Canada Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Canada 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Japan
Market Overview
Brief Note on COVID-19 Testing in Japan
Demographics Drive Market Growth
Market Analytics
Japan Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Japan Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Japan 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Japan Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Japan 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Japan Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Japan 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
China
Market Overview
COVID-19 Testing: An Overview
HPV Testing in China
Market Analytics
China Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
China Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
China 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
China Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
China Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
China 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
China Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
China Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
China 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Europe
Market Overview
COVID-19 Testing Drives Revenue Growth
Aging Population: A Prime Growth Driver
Automated Systems Gain Preeminence
Oncology-based Molecular Diagnostics Holds Immense Potential
HPV Testing in Europe: An Overview
Market Analytics
Europe Current & Future Analysis for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
Europe Historic Review for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Europe 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Europe 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Europe 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Europe 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
France
France Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
France Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
France 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
France Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
France Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
France 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
France Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
France Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
France 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Germany
Germany Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Germany Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Germany 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Germany Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Germany 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Germany Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Germany 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Italy
Italy Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Italy Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Italy 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Italy Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Italy 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Italy Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Italy 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
United Kingdom
UK Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UK Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UK 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UK Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UK 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UK Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UK 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Spain
Spain Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Spain Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Spain 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Spain Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Spain 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Spain Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Spain 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Russia
Russia Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Russia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Russia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Russia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Russia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Russia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Russia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Rest of Europe
Rest of Europe Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Europe 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Europe 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Europe 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Asia-Pacific
Market Overview
Healthcare Spending in Asia-Pacific: On the Rise
Market Analytics
Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
Asia-Pacific Historic Review for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Australia
Australia Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Australia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Australia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Australia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Australia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Australia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Australia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
India
Market Overview
Laboratories Pick up on Automation
HPV Testing Market: An Overview
Market Analytics
India Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
India Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
India 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
India Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
India Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
India 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
India Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
India Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
India 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
South Korea
South Korea Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
South Korea Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
South Korea 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
South Korea Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
South Korea 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
South Korea Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
South Korea 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Rest of Asia-Pacific
Rest of Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Latin America
Latin America Current & Future Analysis for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
Latin America Historic Review for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Latin America 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Latin America 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Latin America 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Latin America 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Argentina
Argentina Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Argentina Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Argentina 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Argentina Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Argentina 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Argentina Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Argentina 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Brazil
Brazil Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Brazil Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Brazil 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Brazil Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Brazil 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Brazil Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Brazil 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Mexico
Mexico Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Mexico Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Mexico 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Mexico Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Mexico 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Mexico Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Mexico 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Rest of Latin America
Rest of Latin America Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Middle East
Middle East Current & Future Analysis for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
Middle East Historic Review for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Middle East 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Middle East 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Middle East 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Middle East 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Iran
Iran Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Iran Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Iran 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Iran Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Iran 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Iran Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Iran 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Israel
Israel Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Israel Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Israel 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Israel Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Israel 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Israel Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Israel 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Saudi Arabia
Saudi Arabia Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Saudi Arabia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Saudi Arabia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Saudi Arabia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
United Arab Emirates
UAE Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UAE Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UAE 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UAE Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UAE 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UAE Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UAE 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Rest of Middle East
Rest of Middle East Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Africa
Africa Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Africa Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Africa 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Africa Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Africa 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Africa Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Africa 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled : 84

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com